Olof Dahlqvist Leinhard

Company: AMRA Medical

Job title: Chief Executive Officer & Founder

Seminars:

MRI-based Body Composition Reimagined: Building a New Foundation for Treatment Differentiation Beyond Weight Loss 12:00 pm

FDA-cleared MRI-based body composition analysis provides a new standard for muscle and fat quantification enabling translation from population studies and clinical trials all the way into healthcare. Studies on Personalized Fat and Muscle Z-score biomarkers show improved prediction of outcomes and that weight- and BMI-invariant treatment effects can be detected. Exploring the varying effects of…Read more

day: Conference Day One